| Intra-and inter-cellular rewiring of the human colon during ulcerative colitis CS Smillie, M Biton, J Ordovas-Montanes, KM Sullivan, G Burgin, ... Cell 178 (3), 714-730. e22, 2019 | 1114 | 2019 |
| A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients AB Hall, M Yassour, J Sauk, A Garner, X Jiang, T Arthur, GK Lagoudas, ... Genome medicine 9, 1-12, 2017 | 693 | 2017 |
| Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases AN Ananthakrishnan, C Luo, V Yajnik, H Khalili, JJ Garber, BW Stevens, ... Cell host & microbe 21 (5), 603-610. e3, 2017 | 418 | 2017 |
| Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability J Luther, JJ Garber, H Khalili, M Dave, SS Bale, R Jindal, DL Motola, ... Cellular and molecular gastroenterology and hepatology 1 (2), 222-232. e2, 2015 | 307 | 2015 |
| Efficacy of vedolizumab as induction therapy in refractory IBD patients: a multicenter cohort E Shelton, JR Allegretti, B Stevens, M Lucci, H Khalili, DD Nguyen, J Sauk, ... Inflammatory bowel diseases 21 (12), 2879-2885, 2015 | 224 | 2015 |
| EUS findings in patients with autoimmune pancreatitis JJ Farrell, J Garber, D Sahani, WR Brugge Gastrointestinal endoscopy 60 (6), 927-936, 2004 | 217 | 2004 |
| Effect of accelerated infliximab induction on short-and long-term outcomes of acute severe ulcerative colitis: a retrospective multicenter study and meta-analysis N Nalagatla, K Falloon, G Tran, NZ Borren, D Avalos, J Luther, F Colizzo, ... Clinical Gastroenterology and Hepatology 17 (3), 502-509. e1, 2019 | 118 | 2019 |
| Genetic markers predict primary non-response and durable response to anti-TNF biologic therapies in Crohn’s disease GE Barber, V Yajnik, H Khalili, C Giallourakis, J Garber, R Xavier, ... Official journal of the American College of Gastroenterology| ACG 111 (12 …, 2016 | 101 | 2016 |
| Visceral adiposity, genetic susceptibility, and risk of complications among individuals with Crohn's disease KWJ Van Der Sloot, AD Joshi, DR Bellavance, KK Gilpin, KO Stewart, ... Inflammatory bowel diseases 23 (1), 82-88, 2017 | 88 | 2017 |
| Body mass index, genetic susceptibility, and risk of complications among individuals with Crohn's disease PL Pringle, KO Stewart, JM Peloquin, HC Sturgeon, D Nguyen, J Sauk, ... Inflammatory bowel diseases 21 (10), 2304-2310, 2015 | 88 | 2015 |
| Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation J Luther, S Khan, MK Gala, D Kedrin, G Sridharan, RP Goodman, ... Proceedings of the National Academy of Sciences 117 (21), 11667-11673, 2020 | 75 | 2020 |
| Vedolizumab therapy is associated with an improvement in sleep quality and mood in inflammatory bowel diseases BW Stevens, NZ Borren, G Velonias, G Conway, T Cleland, E Andrews, ... Digestive diseases and sciences 62, 197-206, 2017 | 65 | 2017 |
| Alterations in fecal microbiomes and serum metabolomes of fatigued patients with quiescent inflammatory bowel diseases NZ Borren, D Plichta, AD Joshi, G Bonilla, V Peng, FP Colizzo, J Luther, ... Clinical Gastroenterology and Hepatology 19 (3), 519-527. e5, 2021 | 59 | 2021 |
| Identification and characterization of a novel association between dietary potassium and risk of Crohn’s disease and ulcerative colitis H Khalili, S Malik, AN Ananthakrishnan, JJ Garber, LM Higuchi, A Joshi, ... Frontiers in immunology 7, 554, 2016 | 56 | 2016 |
| Longitudinal trajectory of fatigue with initiation of biologic therapy in inflammatory bowel diseases: a prospective cohort study NZ Borren, W Tan, FP Colizzo, J Luther, JJ Garber, H Khalili, ... Journal of Crohn's and Colitis 14 (3), 309-315, 2020 | 55 | 2020 |
| ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial DA Drew, SM Chin, KK Gilpin, M Parziale, E Pond, MM Schuck, K Stewart, ... Trials 18, 1-11, 2017 | 52 | 2017 |
| Impact of specialized inpatient IBD care on outcomes of IBD hospitalizations: a cohort study CCY Law, S Sasidharan, R Rodrigues, DD Nguyen, J Sauk, J Garber, ... Inflammatory bowel diseases 22 (9), 2149-2157, 2016 | 52 | 2016 |
| Model to determine the optimal dietary elimination strategy for treatment of eosinophilic esophagitis T Zhan, A Ali, JG Choi, M Lee, J Leung, ES Dellon, JJ Garber, C Hur Clinical Gastroenterology and Hepatology 16 (11), 1730-1737. e2, 2018 | 50 | 2018 |
| Genetic markers predict primary nonresponse and durable response to anti–tumor necrosis factor therapy in ulcerative colitis KE Burke, H Khalili, JJ Garber, T Haritunians, DPB McGovern, RJ Xavier, ... Inflammatory bowel diseases 24 (8), 1840-1848, 2018 | 46 | 2018 |
| Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis D Letner, A Farris, H Khalili, J Garber Diseases of the Esophagus 31 (2), dox122, 2018 | 46 | 2018 |
